Browse
Submit Data
Databases
API
Help

Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

TP53 is a master regulator of proteostasis in SMARCB1-deficient malignant rhabdoid tumors

ABSTRACT: Our mechanistic studies shed light on the central role of the proto-oncogene MYC in driving global protein anabolism and the ER stress response. Specifically, the MYC-p19ARF-TP53 axis plays a critical role in regulating proteostasis and an increased demand for protein disposal.

ORGANISM(S): Mus musculus

SUBMITTER: Sahil Seth

PROVIDER: E-MTAB-7497 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

ACCESS DATA

Json Xml

Similar Datasets

p53 Is a Master Regulator of Proteostasis in SMARCB1-Deficient Malignant Rhabdoid Tumors.

Project description: Not available

| S-EPMC7876656 | biostudies-literature

Expression profiling following SMARCB1 re-expression in MRT cell lines time course over 14 days

Project description:MRT cell lines KD, SWOH, LM, DEV and G401 were expression profiled following SMARCB1 re-expression using a lentivirus. Samples were taken at Day 0,1,3,7 and 14 and compared to empty vector control experiments.

2024-12-31 | E-MTAB-6674 | biostudies-arrayexpress

Transcriptional response to Smarcb1 re-expression in murine derived Smarcb1 deficient p53 null tumors

Project description:SMARCB1 (Snf5/Ini1/Baf47) is a potent tumor suppressor, the loss of which serves as the diagnostic feature in Malignant Rhabdoid Tumors (MRT) and Atypical Teratoid/Rhabdoid Tumors (AT/RT), two highly aggressive forms of pediatric neoplasms. Here, we restore Smarcb1 expression in cells derived from Smarcb1-deficient tumors which developed in Smarcb1-heterozygous p53-/- mice. Profiling Smarcb1 dependent gene expression we find genes which are dependent on Smarcb1 expression to be enriched for ECM and cell adhesion functions. We identify Igfbp7, which is related to the insulin-like growth factor binding proteins family, as a downstream target of Smarcb1 transcriptional activity, and show that re-introduction of Igfbp7 alone can hinder tumor development. Two cancer cell lines, 167 and 365, derived from Smarcb1-deficient tumors which developed in Smarcb1-heterozygous p53-/- mice were re-infected with a retro-viral vector for Smarcb1 re-expression or an empty retro-viral vector as control. Total-RNA was collected 3 days post infection so as to enrich for direct targets of Smarcb1 transcriptionaly regulated genes

2013-12-31 | E-GEOD-46017 | biostudies-arrayexpress

Mechanisms by which SMARCB1 loss drives rhabdoid tumor growth.

Project description: Not available

| S-EPMC4195815 | biostudies-literature

Timing of Smarcb1 and Nf2 inactivation determines schwannoma versus rhabdoid tumor development.

Project description: Not available

| S-EPMC5563506 | biostudies-literature

High prevalence of SMARCB1 constitutional abnormalities including mosaicism in malignant rhabdoid tumors.

Project description: Not available

| S-EPMC7381660 | biostudies-literature

SMARCB1 loss activates patient-specific distal oncogenic enhancers in malignant rhabdoid tumors.

Project description: Not available